end stage cancer - Nursing Case Study
Pathophysiology
• Primary mechanism: Uncontrolled Cellular Proliferation - Cancer cells bypass normal regulatory mechanisms, leading to unchecked growth and tumor development, often due to mutations in oncogenes and tumor suppressor genes.
• Secondary mechanism: Metastasis - Cancer cells invade surrounding tissues and enter the bloodstream or lymphatic system, spreading to distant organs, which disrupts normal organ function and complicates treatment.
• Key complication: Cachexia - A complex syndrome characterized by severe weight loss, muscle wasting, and fatigue, resulting from tumor-induced metabolic changes and inflammatory responses, significantly impacting patient quality of life and survival.
Patient Profile
Demographics:
65-year-old female, retired school teacher
History:
• Key past medical history: Diagnosed with stage IV lung cancer 18 months ago, hypertension, type 2 diabetes
• Current medications: Chemotherapy regimen (Cisplatin and Pemetrexed), Metformin, Lisinopril, Morphine for pain management
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing shortness of breath and fatigue
• Key symptoms: Persistent cough, significant weight loss, occasional confusion, difficulty breathing at rest, swelling in the legs
• Vital signs: Blood pressure 150/90 mmHg, heart rate 110 bpm, respiratory rate 28 breaths per minute, temperature 99.1°F, oxygen saturation 85% on room air
Section 1
New Complications:
The patient, Mrs. Johnson, has been admitted to the oncology unit for further evaluation due to her worsening symptoms. During her stay, she develops new complications, including pleural effusion and worsening of her cachexia. The pleural effusion is confirmed through a chest X-ray, revealing a significant fluid accumulation in the right pleural cavity. This finding correlates with her increased shortness of breath and is likely due to metastatic involvement, which is common in advanced lung cancer. The effusion exacerbates her respiratory distress, causing her oxygen saturation to drop further to 80% on room air, necessitating supplemental oxygen therapy.
In addition, Mrs. Johnson’s cachexia has progressed, as evidenced by a recent weight loss of 10 pounds over the past month despite nutritional interventions. Her laboratory results show hypoalbuminemia with a serum albumin level of 2.8 g/dL and elevated inflammatory markers, including a C-reactive protein level of 15 mg/L. These findings indicate a systemic inflammatory response and a significant nutritional deficit. The interdisciplinary team, including a dietitian, is consulted to optimize her nutritional support and consider the potential initiation of parenteral nutrition if oral intake remains insufficient.
As the healthcare team strategizes the management plan, the focus is on addressing the pleural effusion through thoracentesis to relieve her respiratory symptoms and modifying her pain management regimen to improve her quality of life. These developments require careful monitoring and reassessment of Mrs. Johnson’s overall condition, considering the potential impact on her prognosis and the need for palliative care interventions to support her and her family during this challenging time.
Section 2
Change in Patient Status:
Following the initial interventions, Mrs. Johnson's condition exhibits both stabilization and further decline in certain areas. After the thoracentesis procedure, 1.5 liters of fluid was successfully removed from her right pleural cavity, which led to an immediate improvement in her respiratory status. Her oxygen saturation increased to 92% while on supplemental oxygen at 2 liters per minute via nasal cannula. She reports a noticeable reduction in shortness of breath and is able to engage in brief conversations without significant distress. This improvement in her respiratory parameters is a positive outcome, suggesting that the thoracentesis effectively alleviated the mechanical pressure on her lungs caused by the effusion.
However, her cachexia continues to be a significant concern. Despite the collaborative efforts of the healthcare team to enhance her nutritional intake, Mrs. Johnson's oral intake remains minimal, and she frequently reports a lack of appetite and early satiety. Her weight has decreased further to 95 pounds, and recent laboratory tests show her serum albumin level has dropped to 2.5 g/dL, indicating worsening nutritional status. Additionally, her liver function tests reveal elevated alkaline phosphatase and gamma-glutamyl transferase levels, raising concerns about possible hepatic involvement or biliary obstruction, which could be contributing to her deteriorating nutritional state.
The interdisciplinary team, including her oncologist, palliative care specialist, and dietitian, convenes to reassess her management plan. The focus shifts towards initiating parenteral nutrition to address her severe nutritional deficit and ensure adequate caloric and nutrient intake. Furthermore, the team discusses the potential implications of her declining liver function, considering imaging studies to evaluate for hepatic metastasis or biliary obstruction. These developments highlight the complexity of Mrs. Johnson's condition and the necessity for continuous reassessment and adjustment of her care plan to address both her immediate symptoms and the underlying disease progression.
Section 3
New Diagnostic Results:
Following the interdisciplinary team's decision to further investigate Mrs. Johnson's hepatic function concerns, a comprehensive abdominal ultrasound and a CT scan of the liver were ordered. The imaging studies revealed multiple hypodense lesions within the liver, raising suspicion for metastatic disease. Additionally, there was evidence of mild intrahepatic biliary ductal dilation, suggesting a partial obstruction likely caused by the lesions. These findings correlate with the recent rise in her liver enzymes and contribute to the understanding of her declining nutritional status and cachexia.
Concurrently, Mrs. Johnson's lab results show a further decline in her complete blood count, with a hemoglobin level dropping to 8.1 g/dL, indicating anemia of chronic disease likely exacerbated by her cancer progression and poor nutritional intake. Her platelet count also shows a mild decrease to 130,000/mm³, necessitating close monitoring for any signs of bleeding or bruising. Despite this, her renal function remains stable, with creatinine levels at 1.0 mg/dL, reflecting adequate hydration and kidney perfusion.
These new diagnostic results prompt the healthcare team to adjust Mrs. Johnson's management strategy. The oncologist discusses the possibility of palliative radiation therapy to the liver to potentially alleviate symptoms related to the hepatic lesions and biliary obstruction. Meanwhile, the dietitian emphasizes the initiation of parenteral nutrition to bypass the compromised gastrointestinal absorption and provide essential nutrients intravenously. This comprehensive approach aims to address the multifaceted challenges presented by her advancing cancer, highlighting the need for ongoing evaluation and adaptation of her care plan to improve her quality of life.
Section 4
Response to Interventions:
In the days following the initiation of palliative radiation therapy and parenteral nutrition, Mrs. Johnson shows some signs of symptomatic relief, though her overall condition remains fragile. The radiation therapy has begun to provide mild improvement in her abdominal discomfort, and there is a slight decrease in her liver enzymes, indicating a potential reduction in hepatic inflammation and pressure. However, her parenteral nutrition is met with challenges. Mrs. Johnson develops mild hyperglycemia, with blood glucose levels peaking at 180 mg/dL, necessitating close monitoring and the introduction of sliding scale insulin to maintain glycemic control.
Despite these interventions, her anemia persists with a hemoglobin level stagnating at 8.3 g/dL. She reports increased fatigue, and her physical examination reveals pallor and mild tachycardia, with a heart rate of 102 beats per minute. Her blood pressure remains stable at 110/70 mmHg, but her oxygen saturation slightly dips to 92% on room air, prompting the addition of supplemental oxygen to alleviate any hypoxic symptoms. The healthcare team considers a transfusion to address her anemia, weighing the benefits against the potential risks in her fragile state.
As Mrs. Johnson continues her treatment, the interdisciplinary team remains vigilant for any new complications. Her platelet count holds steady at 128,000/mm³, but the team is alert for any signs of bleeding or bruising, given her overall declining health. The focus shifts to maintaining her comfort and quality of life, with regular assessments to adjust her care plan as needed. This ongoing evaluation underscores the importance of adapting interventions to manage the dynamic challenges of her end-stage cancer, ensuring that each decision supports her dignity and well-being.
Section 5
New Complications:
In the following days, Mrs. Johnson begins to exhibit signs of new complications, which require immediate attention from the healthcare team. She develops increased abdominal distension and reports nausea and intermittent vomiting, which are concerning for potential bowel obstruction, a common complication in advanced cancer. Her abdominal examination reveals hypoactive bowel sounds and mild tenderness upon palpation, raising suspicion of decreased gastrointestinal motility. A subsequent abdominal X-ray confirms the presence of dilated loops of bowel, indicating partial obstruction. The team initiates conservative management, including bowel rest and nasogastric decompression, to alleviate her symptoms and prevent further complications.
Additionally, Mrs. Johnson's laboratory results show a slight increase in her serum creatinine, now at 1.6 mg/dL, up from her baseline of 1.2 mg/dL, suggesting a decline in renal function. This change prompts the team to review her medication regimen and hydration status, as these could be contributing factors. Her fluid intake is closely monitored, and adjustments are made to her parenteral nutrition to ensure adequate hydration while avoiding fluid overload. The interdisciplinary team discusses the potential need for nephrology consultation to address her renal concerns and to explore additional supportive measures.
These developments necessitate careful clinical reasoning and a proactive approach to manage Mrs. Johnson's evolving condition. The team remains vigilant in assessing her response to the interventions for bowel obstruction and renal impairment, while continuing to prioritize her comfort and quality of life. As they navigate these new challenges, the focus remains on maintaining a holistic and patient-centered approach, ensuring that each decision reflects Mrs. Johnson's goals and preferences in her end-of-life care journey.